Virgilijus Uloza
Kaunas, KU 44307, Lithuania
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications
Toward Standardized Assessment of Dynamic Subjective Visual Vertical: Effects of Visual Stimulus Intensity in Health and Multiple Sclerosis.
Journal: Medicina (Kaunas, Lithuania)
Published: July 18, 2025
Assessment of the Performance of an AI-Driven SpeechEnhancer Algorithm for Speech Enhancement Following Laryngeal Oncosurgery.
Journal: Journal of voice : official journal of the Voice Foundation
Published: January 14, 2025
Verticality perception in patients with active multiple sclerosis: The applicability of subjective visual vertical test and its modifications.
Journal: Multiple sclerosis and related disorders
Published: November 03, 2024
The Association of TP53, BCL2, BAX and NOXA SNPs and Laryngeal Squamous Cell Carcinoma Development.
Journal: International journal of molecular sciences
Published: September 16, 2024
Alaryngeal Speech Enhancement for Noisy Environments Using a Pareto Denoising Gated LSTM.
Journal: Journal of voice : official journal of the Voice Foundation
Published: June 10, 2024
Accuracy Analysis of the Multiparametric Acoustic Voice Indices, the VWI, AVQI, ABI, and DSI Measures, in Differentiating between Normal and Dysphonic Voices.
Journal: Journal of clinical medicine
Published: November 16, 2023
The association of E2F1 and E2F2 single nucleotide polymorphisms with laryngeal squamous cell carcinoma pathomorphological features.
Journal: BMC cancer
Published: November 07, 2023
Smartphone-Based Voice Wellness Index Application for Dysphonia Screening and Assessment: Development and Reliability.
Journal: Journal of voice : official journal of the Voice Foundation
Published: July 17, 2023
Reliability of Universal-Platform-Based Voice Screen Application in AVQI Measurements Captured with Different Smartphones.
Journal: Journal of clinical medicine
Published: June 05, 2023
The survival rate of laryngeal squamous cell carcinoma: impact of IL1RAP rs4624606, IL1RL1 rs1041973, IL-6 rs1800795, BLK rs13277113, and TIMP3 rs9621532 single nucleotide polymorphisms.
Journal: Discover oncology
Published: November 18, 2022
Last Updated: 09/26/2026